temazepam has been researched along with Hepatitis C in 1 studies
Temazepam: A benzodiazepine that acts as a GAMMA-AMINOBUTYRIC ACID modulator and anti-anxiety agent.
Hepatitis C: INFLAMMATION of the LIVER in humans caused by HEPATITIS C VIRUS, a single-stranded RNA virus. Its incubation period is 30-90 days. Hepatitis C is transmitted primarily by contaminated blood parenterally and is often associated with transfusion and intravenous drug abuse. However, in a significant number of cases, the source of hepatitis C infection is unknown.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aitken, CK | 1 |
| Higgs, P | 1 |
1 other study available for temazepam and Hepatitis C
| Article | Year |
|---|---|
Severe vein damage caused by Temezepam injecting.
Topics: Adult; Anti-Anxiety Agents; Hepatitis C; Humans; Male; National Health Programs; Social Work; Substa | 2002 |